Abstract
* The Food and Drug Administration is requiring manufacturers of metformin and metformin-containing drugs to revise their labeling to indicate that metformin may be safely used in some patients with mild-to-moderate renal dysfunction.
* Nurses should regularly assess patients' estimated glomerular filtration rate to confirm that renal function remains adequate to support metformin therapy.